Long Story Short Episode 62: Therapeutic Apheresis and Long COVID

This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte stacking when extracorporeal apheresis is performed. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.

DrBeen: Medical Education Online
https://www.drbeen.com/

FLCCC | Front Line COVID-19 Critical Care Alliance
https://covid19criticalcare.com/

URL list from Thursday, July 13, 2023

Home - FLCCC | Front Line COVID-19 Critical Care Alliance
https://covid19criticalcare.com/

Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis | Molecular Psychiatry
https://www.nature.com/articles/s41380-023-02084-1#additional-information

Thieme E-Journals - Hormone and Metabolic Research / Full Text
https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1945-9694

INUSpherese®: BIOLOGICUM⁺
https://biologicum.info/inuspherese/

Apheresis - Wikipedia
https://en.wikipedia.org/wiki/Apheresis

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
CSID: b7027dfefb781596

Content Managed by ContentSafe.co